Infusion pump

IoT Medical Devices to Reach USD 58.33 Billion by 2027 at a CAGR of 19.85% | Valuates Reports

Retrieved on: 
Tuesday, January 4, 2022
Safety, Growth, Pulse oximetry, Arthritis, Conditional sentence, CAGR, The Hospital, Cancer, Caregiver, Heart rate, Health, EHealth, Solution, Hospital, USD, Incidence, Patient, Lists of countries and territories, Medical tourism, Adoption, Government, Awareness, Infusion pump, Monitor lizard, Cardiovascular disease, IOT, Medical device, Risk management

Global revenue for IoT Medical Devices was valued at USD 16.25 Billion in 2020 and is expected to generate revenue of USD 58.33 Billion by end of 2027, growing at a CAGR of 19.85% between 2021 and 2027.

Key Points: 
  • Global revenue for IoT Medical Devices was valued at USD 16.25 Billion in 2020 and is expected to generate revenue of USD 58.33 Billion by end of 2027, growing at a CAGR of 19.85% between 2021 and 2027.
  • This, in turn, is expected to fuel the growth of the IoT medical devices market.
  • Advances in communication technologies, such as real-time data transmission, have improved patients' ability to manage chronic diseases and medication dosage, thereby fueling IoT medical devices' market growth.
  • Furthermore, the IoT medical devices market is expanding as a result of a greater emphasis on patient-centered care delivery.

IoT Medical Devices to Reach USD 58.33 Billion by 2027 at a CAGR of 19.85% | Valuates Reports

Retrieved on: 
Tuesday, January 4, 2022
Safety, Growth, Pulse oximetry, Arthritis, Conditional sentence, CAGR, The Hospital, Cancer, Caregiver, Heart rate, Health, EHealth, Solution, Hospital, USD, Incidence, Patient, Lists of countries and territories, Medical tourism, Adoption, Government, Awareness, Infusion pump, Monitor lizard, Cardiovascular disease, IOT, Medical device, Risk management

Global revenue for IoT Medical Devices was valued at USD 16.25 Billion in 2020 and is expected to generate revenue of USD 58.33 Billion by end of 2027, growing at a CAGR of 19.85% between 2021 and 2027.

Key Points: 
  • Global revenue for IoT Medical Devices was valued at USD 16.25 Billion in 2020 and is expected to generate revenue of USD 58.33 Billion by end of 2027, growing at a CAGR of 19.85% between 2021 and 2027.
  • This, in turn, is expected to fuel the growth of the IoT medical devices market.
  • Advances in communication technologies, such as real-time data transmission, have improved patients' ability to manage chronic diseases and medication dosage, thereby fueling IoT medical devices' market growth.
  • Furthermore, the IoT medical devices market is expanding as a result of a greater emphasis on patient-centered care delivery.

Insights on the Intravenous Infusion Pumps Global Market to 2027 - by Type, Application, End User and Region - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 23, 2021
Medical Devices, Health, Institute, Conditional sentence, Patient, Approximation error, Nutrient, Insulin, Patient safety, Pump, Globe, Diabetes, Social behavior, Neuromuscular blocking agents, Growth, Ageing, Urbanization, Chronic pain, COVID-19, Travel, Population, Cancer, Prevalence, Institute of Medicine, Nepal, Application, Intravenous therapy, CAGR, Adoption, Death, Infusion pump, PADE, Medical device, Pharmaceutical industry

The "Global Intravenous Infusion Pumps Market By Type, By Application, By End User, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Intravenous Infusion Pumps Market By Type, By Application, By End User, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027" report has been added to ResearchAndMarkets.com's offering.
  • The Global Intravenous Infusion Pump Market size is expected to reach $8.2 billion by 2027, rising at a market growth of 8.5% CAGR during the forecast period.
  • There are many companies that are increasingly investing in the advancement of infusion pump technology, which is expected to open new growth opportunities for the intravenous infusion pumps market.
  • One of the key factors fueling the growth of the Intravenous infusion pumps market is the rising prevalence of various chronic diseases.

Infusion Pumps Market is Expected to Grow at a CAGR of 9.53% and is Anticipated to Reach USD 20.75 Billion by 2026, Estimates DelveInsight

Retrieved on: 
Monday, November 29, 2021
Patient, Skin, Insulin, DASH, Boston Scientific, Technology, Nursing, US Foods, Diabetes, Infusion pump, Hospital, Population, CAGR, Hormone, Tandem, Pump, Nutrient, Prevalence, USD, Fresenius (company), COVID-19, Pain, Chronic pain, CareFusion, FDA, Medicine, Growth, Medtronic, Baxter International, Food, Medical device

LAS VEGAS, Nov. 29, 2021 /PRNewswire/ -- DelveInsight's Infusion Pump Market Insights and Forecast report provide the current and forecast Infusion Pumps market, upcoming innovation in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Infusion Pumps market.

Key Points: 
  • LAS VEGAS, Nov. 29, 2021 /PRNewswire/ -- DelveInsight's Infusion Pump Market Insights and Forecast report provide the current and forecast Infusion Pumps market, upcoming innovation in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Infusion Pumps market.
  • Some of the salient features from the Infusion Pump Market report:
    As per an analysis by DelveInsight, North America is expected to dominate the overall Infusion Pumps market during the forecast period.
  • DelveInsight estimates that Global Infusion Pumps Market was valued at USD 12.67 billion in 2020, growing at a CAGR of 9.53% during the forecast period from 2021 to 2026, to reach USD 20.75 billion.
  • To get a deeper understanding of the driving factors related to the Infusion Pumps market, get a snapshot of the Infusion Pumps Market Dynamics

Infusion Pumps Market is Expected to Grow at a CAGR of 9.53% and is Anticipated to Reach USD 20.75 Billion by 2026, Estimates DelveInsight

Retrieved on: 
Monday, November 29, 2021
Patient, Skin, Insulin, DASH, Boston Scientific, Technology, Nursing, US Foods, Diabetes, Infusion pump, Hospital, Population, CAGR, Cancer, Tandem, Pump, Prevalence, Nutrient, Hormone, USD, Fresenius (company), Food, COVID-19, Chronic pain, Pain, CareFusion, FDA, LAS, Medicine, Medtronic, Baxter International, Growth, Medical device

LAS VEGAS, Nov. 29, 2021 /PRNewswire/ -- DelveInsight's Infusion Pump Market Insights and Forecast report provide the current and forecast Infusion Pumps market, upcoming innovation in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Infusion Pumps market. 

Key Points: 
  • LAS VEGAS, Nov. 29, 2021 /PRNewswire/ -- DelveInsight's Infusion Pump Market Insights and Forecast report provide the current and forecast Infusion Pumps market, upcoming innovation in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Infusion Pumps market.
  • Some of the salient features from the Infusion Pump Market report:
    As per an analysis by DelveInsight, North America is expected to dominate the overall Infusion Pumps market during the forecast period.
  • DelveInsight estimates that Global Infusion Pumps Market was valued at USD 12.67 billion in 2020, growing at a CAGR of 9.53% during the forecast period from 2021 to 2026, to reach USD 20.75 billion.
  • To get a deeper understanding of the driving factors related to the Infusion Pumps market, get a snapshot of the Infusion Pumps Market Dynamics

Global $8.4 Bn Intravenous Infusion Pumps (Volumetric, Insulin, Syringe, Enteral, Ambulatory, Implantable Pumps) Markets Analysis & Forecasts, 2016-2020 & 2021-2028 - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 25, 2021
Health, Medical Supplies, Medical Devices, Patient, Blood transfusion, Government, Automation, EMR, Asia, Safety, Technology, Time, Hospital, Lymphatic system, Infusion pump, Diabetes, Baxter, National Institute, Risk, Conditional sentence, Hematology, FDA, National Cybersecurity Center of Excellence, National Institute of Standards and Technology, Method, Medical device

The "Global Intravenous Infusion Pumps Market Report 2021-2028" has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Intravenous Infusion Pumps Market Report 2021-2028" has been added to ResearchAndMarkets.com's offering.
  • According to a study conducted by Mindray Medical Company in 2018, medical pumps are the most conventional hospital rentals equipment.
  • FDA also launched a website that gives peculiar information about medical pumps to the patients, users, and other stakeholders.
  • Chapter 3 Intravenous Infusion Pump Market: Variables, Trends, & Scope
    Chapter 4 Intravenous Infusion Pumps Market: Product Segment Analysis
    4.1.1.1 Volumetric Infusion Pumps market, 2016 - 2028 (USD Million)

Worldwide Clinical Trial Supplies Industry to 2026 - Featuring Almac Group, Catalent Pharma Solutions and DHL Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, November 8, 2021
Pharmaceutical, Health, Clinical Trials, Efficiency, Diagnosis, Clinical trial, Cros, HIV, Non-governmental organization, Research, Industry, Growth, COVID-19, Infusion pump, R, Pharmaceutical industry, Potash

Clinical trial supplies refer to various tools and equipment that are used for conducting scientific experiments, investigations and clinical research.

Key Points: 
  • Clinical trial supplies refer to various tools and equipment that are used for conducting scientific experiments, investigations and clinical research.
  • Infusion pumps, nebulizers and syringe needles are the most commonly used clinical trial supplies.
  • What has been the impact of COVID-19 on the global clinical trial supplies market?
  • What is the structure of the global clinical trial supplies market and who are the key players?

Zealand Pharma and DEKA Research & Development Corp. Announce Collaboration Agreement to Advance Development of Infusion Pump to Be Used with Dasiglucagon for Treatment of Congenital Hyperinsulinism (CHI)

Retrieved on: 
Friday, November 5, 2021
Boehringer Ingelheim, Private Securities Litigation Reform Act, Pump, Carbice Corp. v. American Patents Development Corp., Congenital hyperinsulinism, European Commission, Engineering, Hypoglycemia, Technology, Failure, Food, COVID-19, Treatment, Research, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Advertising, DEKA (company), Structured Product Labeling, DK, Royal commission, Pharma, Infusion pump, Nasdaq, DEKA, Patient, AstraZeneca, FDA, Intellectual property, Pharmaceutical industry

Announce Collaboration Agreement to Advance Development of Infusion Pump to Be Used with Dasiglucagon for Treatment of Congenital Hyperinsulinism (CHI)

Key Points: 
  • Announce Collaboration Agreement to Advance Development of Infusion Pump to Be Used with Dasiglucagon for Treatment of Congenital Hyperinsulinism (CHI)
    Agreement grants Zealand a worldwide, exclusive license to use DEKAs continuous infusion pump for the potential treatment of CHI with dasiglucagon
    Copenhagen, DK and Boston, MA, U.S. November 05, 2021 Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no.
  • The agreement covers the technical development of the pump system as well as associated manufacturing and commercialization activities.
  • Under the terms of the agreement, DEKA and Zealand will develop a medical pump system that is suitable for use in combination with dasiglucagon.
  • Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery, development, and commercialization of peptide-based medicines.

Outlook on the Intravenous Infusion Pump Global Market to 2030 - Rising Demand for Ambulatory Infusion Pumps in Homecare Settings is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 3, 2021
Medical Devices, Health, Infection, Nutrient, Hospital, Nursing, Cancer, Long-term care, Patient, CCU delivery, Insulin, NCBI, Pump, Cardiovascular disease, Disability, Chronic Respiratory Disease, Approximation error, CAGR, Environment, Stroke, Diabetes, WHO, Conditional sentence, Death, Infusion pump, Chronic condition, Prevalence, Incidence, Degenerative disease, Hormone, Medical device

The global intravenous infusion pump market was valued at $4,154.30 million in 2020, and is estimated to reach $8,147.20 million by 2030, growing at a CAGR of 7.10% from 2021 to 2030.

Key Points: 
  • The global intravenous infusion pump market was valued at $4,154.30 million in 2020, and is estimated to reach $8,147.20 million by 2030, growing at a CAGR of 7.10% from 2021 to 2030.
  • Furthermore, infusion pumps can deliver nutrients or medications, such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers.
  • Furthermore, the introduction of smart intravenous infusion pumps or next-generation intravenous pumps is imparting lucrative growth opportunities for the market.
  • Increase in the rate of adopting ambulatory infusion pumps and rise in need to reduce hospital stays are critical factors for surge in demand for ambulatory infusion pumps in homecare settings.

Ivenix selects Eastman Tritan™ copolyester for its new infusion system

Retrieved on: 
Tuesday, October 19, 2021
Love, Tritan, Nutrient, Polymer, Pump, Patient safety, Ammonium chloride, Transport, IV, Eastman, FDA, Quality of life, Medicine, Patient, Disinfectant, Face, Eyeish, Longevity, Subclinical infection, Food, Solution, Infusion pump, Regulation of tobacco by the U.S. Food and Drug Administration, Safety, Corrosion, Medical device, Thermoplastic

BOSTON and KINGSPORT, Tenn., Oct. 19, 2021 /PRNewswire/ -- Medical technology innovator Ivenix collaborated with Eastman to incorporate Eastman Tritan MXF copolyester into its groundbreaking Ivenix Infusion System.

Key Points: 
  • BOSTON and KINGSPORT, Tenn., Oct. 19, 2021 /PRNewswire/ -- Medical technology innovator Ivenix collaborated with Eastman to incorporate Eastman Tritan MXF copolyester into its groundbreaking Ivenix Infusion System.
  • "The Ivenix Infusion System has several key advantages over our competitionone being its durability in real-world clinical environments," said Josh North, director of sales at Ivenix.
  • Visit Ivenix.com or call them at (978) 775-8050 for more information on the Ivenix Infusion System and their approach to revolutionizing infusion delivery.
  • The Ivenix Infusion System includes a large-volume infusion pump, a portfolio of administration sets, and a suite of infusion management tools and analytics to inform care and advance clinical and operational efficiency.